According to our (Global Info Research) latest study, the global Treatment of PNH market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Treatment of paroxysmal nocturnal hemoglobinuria (PNH) focuses on controlling the abnormal destruction of red blood cells caused by complement system dysregulation. The mainstay of treatment involves complement inhibitors, such as Eculizumab and Ravulizumab, which block complement protein C5 to prevent the formation of the membrane attack complex (MAC), reducing hemolysis and the risk of blood clots. In severe cases, supportive care like blood transfusions, iron supplementation, or bone marrow transplantation may be needed.
This report is a detailed and comprehensive analysis for global Treatment of PNH market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Treatment of PNH market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Treatment of PNH market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Treatment of PNH market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Treatment of PNH market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Treatment of PNH
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Treatment of PNH market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Alexion Pharmaceuticals, Roche, Apellis Pharmaceuticals, Amgen, Samsung Bioepis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Treatment of PNH market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Complement Inhibitors
Supportive Care
Others
Market segment by Application
Hospital
Clinic
Other
Major players covered
Novartis
Alexion Pharmaceuticals
Roche
Apellis Pharmaceuticals
Amgen
Samsung Bioepis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Treatment of PNH product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Treatment of PNH, with price, sales quantity, revenue, and global market share of Treatment of PNH from 2021 to 2026.
Chapter 3, the Treatment of PNH competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Treatment of PNH breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Treatment of PNH market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Treatment of PNH.
Chapter 14 and 15, to describe Treatment of PNH sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Treatment of PNH. Industry analysis & Market Report on Treatment of PNH is a syndicated market report, published as Global Treatment of PNH Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Treatment of PNH market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.